Juvenile Arthritis Research

Biologics have been viewed as the new “it” drug to treat autoimmune conditions. These drugs are manufactured in, extracted from, or semi-synthesized from biological sources. Monoclonal antibodies are a form of biologic treatment that are similar to our own immune system antibodies. They can be...

Dr. Lauren Henderson received a BA from Cornell University with majors in neurobiology and psychology. She was first exposed to the importance of clinical research through Postbaccalaureate Intramural Research and Training Program at the National Institutes of Health. After a year at NIH, she moved...

Peter A. Nigrovic, MD, is Associate Professor of Medicine at Harvard Medical School and Associate Physician at Brigham and Women’s Hospital. He is a practicing adult and pediatric rheumatologist and director of the Center for Adults with Pediatric Rheumatic Illness (CAPRI) at the Brigham and...

Early in her career, pediatric rheumatologist, Tiphanie Vogel, MD, PhD, cared for a seven-year-old boy with a rare form of juvenile arthritis (JA). She discovered that her young patient had a specific genetic mutation that damages multiple organs and severely affects the joints. Dr. Vogel, an...

Rheumatoid arthritis (RA) is a cruel disease that ravages the joints, triggering flares of heat, swelling and recurrent pain. Juvenile idiopathic arthritis (JIA) is uniquely devastating, often striking children and teens with unpredictable bouts of severe pain and joint inflammation. Although JIA shares many symptoms...

LONG BEACH, CA – Arthritis National Research Foundation (ANRF), a nonprofit dedicated solely to arthritis research, today announced new members to its world-renowned Scientific Advisory Board. Betty Diamond, M.D. and Paul J. Utz, M.D., Ph.D. will bring their expertise and experience to help fund research...